Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes

Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy

(2015) Sahra Ali et al.   BRITISH JOURNAL OF HAEMATOLOGY

Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia

(2015) H. Gill et al.   HAEMATOLOGICA

Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy

(2015) Frédéric Amant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia

(2015) H. Gill et al.   HAEMATOLOGICA

How I treat leukemia during pregnancy

(2013) D. Milojkovic et al.   BLOOD

Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation

(2013) F. Ravandi et al.   BLOOD

Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor

(2013) Li Zhou et al.   LEUKEMIA RESEARCH